DXS International plc (DXSP) Ordinary 0.33p
No change
- Add to watchlist
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Business summary
DXS International plc is a United Kingdom-based digital clinical decision support company. The Company’s principal activities include the development and distribution of clinical decision support to general practitioners, nurses, and retail pharmacies in the United Kingdom. Its products include BestPathway / Point-of-Care and ExpertCare. Its Point-of-Care (DXS PoC) clinical decision support solution provides clinicians and primary care staff with instant access to clinical guidance, treatment pathways and forms filtered and presented at the appropriate time. ExpertCare is a medicine optimization tool which promotes adherence with NICE guidelines on the management of hypertension and its comorbidities. It is also engaged in licensing of its products to various CCG's (Central Commissioning Groups), the sale of e- detailing opportunities to the pharmaceutical industry, the United Kingdom primary care sector and the licensing of DXS technology to healthcare publishers.
Contact details
Important dates
General stock information
- EPIC:
- DXSP
- ISIN:
- GB00B2Q6HZ92
- Market cap:
- £864,300
- Shares in issue:
- 48.26 million
- Sector:
- Health Care Technology
- Exchange:
- -
- Currency:
- Sterling pence
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.